Matches in Wikidata for { <http://www.wikidata.org/entity/Q64150371> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q64150371 description "clinical trial" @default.
- Q64150371 description "ensayu clínicu" @default.
- Q64150371 description "klinisch onderzoek" @default.
- Q64150371 description "клінічне випробування" @default.
- Q64150371 name "Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)" @default.
- Q64150371 type Item @default.
- Q64150371 label "Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)" @default.
- Q64150371 prefLabel "Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)" @default.
- Q64150371 P1050 Q64150371-B9E84004-7A1F-491C-AC47-5E057E137AD8 @default.
- Q64150371 P1050 Q64150371-C68B02C6-7A1D-48F0-9A34-CD9D96C3BC95 @default.
- Q64150371 P1132 Q64150371-B0AB160A-80B2-41C9-8898-92424DA65B0A @default.
- Q64150371 P1476 Q64150371-ACFB80FA-5AB7-46BA-83E1-A291270B399D @default.
- Q64150371 P17 Q64150371-84949D55-5471-42E5-B334-FCDF06D917A5 @default.
- Q64150371 P2899 Q64150371-2C842B53-88B3-4409-B39B-5421D7E89C7F @default.
- Q64150371 P3098 Q64150371-689509AC-83EC-4FE1-864E-F5A1D990CE45 @default.
- Q64150371 P31 Q64150371-2E9288A6-6063-4902-A32E-2F66B83F4EC0 @default.
- Q64150371 P4135 Q64150371-C449F918-37F4-4B44-A9C9-6B40DE112299 @default.
- Q64150371 P4844 Q64150371-375F8F42-5A32-4867-9465-FA9DEF1E8DC3 @default.
- Q64150371 P4844 Q64150371-BB688754-94E0-43AE-9AA4-A8F5B6A7D3C3 @default.
- Q64150371 P4844 Q64150371-FB34D8F6-F8A0-41C6-846C-26CDA605EE66 @default.
- Q64150371 P580 Q64150371-E833791A-D15A-4894-9B38-508AD5AA46DB @default.
- Q64150371 P582 Q64150371-49291D83-A473-4F29-8E64-0DAEE9DC4AA5 @default.
- Q64150371 P6099 Q64150371-7E9CD9F2-27F7-4575-A725-80971BDD4442 @default.
- Q64150371 P8363 Q64150371-502E3FD0-CF66-416A-9787-21ACE6CEB240 @default.
- Q64150371 P921 Q64150371-0F927211-807B-4B3D-B9DC-B11212DA5760 @default.
- Q64150371 P921 Q64150371-A378EA2D-12B0-4ACB-9D99-614266F22CB5 @default.
- Q64150371 P1050 Q179630 @default.
- Q64150371 P1050 Q29496 @default.
- Q64150371 P1132 "+116" @default.
- Q64150371 P1476 "Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS)" @default.
- Q64150371 P17 Q30 @default.
- Q64150371 P2899 "+2" @default.
- Q64150371 P3098 "NCT02250937" @default.
- Q64150371 P31 Q30612 @default.
- Q64150371 P4135 "+70" @default.
- Q64150371 P4844 Q185916 @default.
- Q64150371 P4844 Q408524 @default.
- Q64150371 P4844 Q414030 @default.
- Q64150371 P580 "2014-10-27T00:00:00Z" @default.
- Q64150371 P582 "2019-10-01T00:00:00Z" @default.
- Q64150371 P6099 Q42824440 @default.
- Q64150371 P8363 Q78089383 @default.
- Q64150371 P921 Q185916 @default.
- Q64150371 P921 Q954625 @default.